Trouble Viewing This Email: Click Here
 

March 14, 2023

FOUNDING MEMBER OF

 
BioTalk Podcast Welcomes Immunyx Pharma Co-Founder & CEO, Seth Salpeter

Want to be on the cutting edge of disease treatment? Learn how companies like Immunyx Pharma are changing the landscape of immune modulation in the battle against diseases with the JLABS/BARDA Blue Knight program on this episode of BioTalk with Rich Bendis.

Available on popular podcast platforms like Apple https://apple.co/3LlbxIy, Google https://bit.ly/3l6O6ba, Spotify https://spoti.fi/405ln5B, Amazon Music https://amzn.to/3J58kde, TuneIn https://bit.ly/3JA8MBO, and even YouTube https://bit.ly/3LhYZS6.

Read More

 
BioHealth Innovation Announces New Life Sciences Business Strategist Mona Suliman, Ph.D.

ROCKVILLE, MARYLAND, March 8, 2023  BioHealth Innovation Inc. (BHI) is pleased to welcome Mona Suliman, Ph.D., as a new Life Sciences Business Strategist. In this role, Mona will evaluate the commercial potential of clients’ emerging technologies and assist start-ups with their go-to-market strategies. Her work will also focus on helping biohealth companies to secure non-dilutive funding.

Mona Suliman has been a consultant in the business and science sectors for over eight years. Her specific areas of focus are entrepreneurship, innovation, strategy, and marketing. She obtained her Master’s in Business Administration from George Mason University and her Ph.D. in Biochemistry from Virginia Commonwealth University in Richmond. As a consultant, she supported companies in developing marketing strategies and creating product launch plans and development strategies.

Read More

 
Save the date for the 9th Annual BioHealth Capital Region Forum on September 19th and 20th, 2023!

Save the date for the 9th Annual BioHealth Capital Region Forum on September 19th and 20th, 2023! Join us for two days of highlighting innovation and entrepreneurship as we bring together the best of our region and beyond to collaborate and shape the future of healthcare. Location and registration information coming soon.

Read More

 
Diabetes drug Tzield yields Rockville's MacroGenics a big check for royalty stake - Washington Business Journal

The deal stands to drive hundreds of millions more to the local company over time.

Image: Scott Koenig is president and CEO of Rockville's MacroGenics. JOANNE S. LAWTON

Read More

 
MIMETAS Launches Ready-to-Use 3D Adult Stem Cell Organoid Tubules

LEIDEN, the Netherlands, March 07 / B3C newswire / -- MIMETAS, a leading company in the field of organ-on-a-chip-based disease models, announces that it has launched its Adult Stem Cell (ASC)-derived tubular organoids in an assay-ready format. As part of its OrganoReady® product line, MIMETAS offers two organoid-based products: ASC-derived Colon1 and Kidney2 Organoid tubules.

“We are thrilled to offer this cutting-edge technology to the research community,” says Jos Joore, co-CEO of MIMETAS. “We’ve worked for several years to optimize these OrganoReady® organoid products. As a result, our early-access users will be the first in the world to have license-free access to ready-to-use, donor-relevant organoid tubules of consistent quality.”

Read More

 
Can we trust AI? | Hub

In the field of artificial intelligence, there are winters and there are springs—barren stretches followed by exhilarating bursts of innovation and funding. Right now, we find ourselves definitively in the midst of an AI spring, says Johns Hopkins engineer Rama Chellappa, a veteran of the industry for more than four decades.

Read More

 
March 30, 2023 Biotech & Beer – The Institute for Biohealth Innovation

Join us and guest speaker John Newby, CEO of Virginia Bio, who will be highlighting strategic goals for Virginia Bio and Virginia Bio-Connect as well as discussing the future of biotech collaborations and partnerships in the DMV region. Enjoy an evening of networking, drinks, and fun!

Read More

 
Intro to Quantum for Life Sciences Tickets, Tue, Mar 28, 2023 at 12:00 PM | Eventbrite

Join us for a lunch and learn to hear how new technologies in quantum computing will be utilized to power scientific research and the life science companies already taking advantage. Shahar Keinan, CEO, and Maurice Benson, Lead Software Engineer at POLARISqb, will give a presentation on how the innovations in the quantum computing industry will directly impact the future of drug design, clinical research, and precision medicine. POLARISqb has created one of the first platforms for the life sciences industry that can cut the drug discovery research process timeline from its traditional time of 5 years down to 4 months. Shahar and Maurice will also discuss how quantum computers are beginning to be made ready for commercial use and all of the recent case studies on their performance.

Read More

Home | About BHI | BHI News | Programs | Partners | Contact

Copyright  BioHealth Innovation 2023
All Rights Reserved.